Your browser doesn't support javascript.
loading
An intensified dosing schedule of subcutaneous methotrexate in patients with moderate to severe plaque-type psoriasis (METOP): a 52 week, multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Warren, Richard B; Mrowietz, Ulrich; von Kiedrowski, Ralph; Niesmann, Johannes; Wilsmann-Theis, Dagmar; Ghoreschi, Kamran; Zschocke, Ina; Falk, Thomas M; Blödorn-Schlicht, Norbert; Reich, Kristian.
Afiliación
  • Warren RB; Dermatology Centre, Salford Royal NHS Foundation Trust, University of Manchester and Manchester Academic Health Science Centre, Manchester, UK.
  • Mrowietz U; Psoriasis-Center, Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • von Kiedrowski R; Company for Medical Study & Service Selters (CMS3) GmbH, Selters, Germany.
  • Niesmann J; Hautarzt Gemeinschaftspraxis, Bochum, Germany.
  • Wilsmann-Theis D; Department of Dermatology and Allergy, University of Bonn, Bonn, Germany.
  • Ghoreschi K; Department of Dermatology, University Medical Center, Eberhard Karls University Tübingen, Tübingen, Germany.
  • Zschocke I; SCIderm GmbH Hamburg, Hamburg, Germany.
  • Falk TM; Dermatologikum Hamburg, Hamburg, Germany.
  • Blödorn-Schlicht N; Dermatologikum Hamburg, Hamburg, Germany.
  • Reich K; SCIderm GmbH Hamburg, Hamburg, Germany; Dermatologikum Hamburg, Hamburg, Germany. Electronic address: kreich@dermatologikum.de.
Lancet ; 389(10068): 528-537, 2017 02 04.
Article en En | MEDLINE | ID: mdl-28012564

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Metotrexato / Inmunosupresores Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Psoriasis / Metotrexato / Inmunosupresores Tipo de estudio: Clinical_trials / Etiology_studies / Observational_studies Límite: Adolescent / Adult / Aged / Humans / Middle aged Idioma: En Revista: Lancet Año: 2017 Tipo del documento: Article País de afiliación: Reino Unido